Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuria	Active, not recruiting	Phase 3	2026-07-21		NCT05270837

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioMarin Pharmaceutical	32

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann and Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	14
Arkansas Children's Hospital	Little Rock	United States	82
Boston Children's Hospital	Boston	United States	343
Charité - Universitätsmedizin Berlin	Berlin	Germany	21
Children's Hospital of Colorado	Aurora	United States	28
Children's Hospital of Wisconsin	Milwaukee	United States	87
IU Health University Hospital	Indianapolis	United States	15
McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth)	Houston	United States	1
Phoenix Children's Hospital	Phoenix	United States	95
Universitat Mainz	Mainz	Germany	1
University of Kentucky College of Medicine	Lexington	United States	3
University of Pittsburgh Medical Center	Pittsburgh	United States	18
University of South Florida	Tampa	United States	65
University of Utah Medical Center	Salt Lake City	United States	5
University of Virginia School of Medicine	Charlottesville	United States	6
Universitätsklinikum Hamburg-Eppendorf	Hamburg	Germany	31